Products
Platform
Research
Market
Learn
IPO
Compare ICICI Prudential Nifty Pharma Index Fund vs UTI Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 0.98 | 2.26 |
NAV | ₹17.41 | ₹288.00 |
Fund Started | 25 Nov 2022 | 01 Aug 2005 |
Fund Size | ₹90.82 Cr | ₹1124.88 Cr |
Exit Load | - | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹1000
₹500
Expense Ratio
0.98
2.26
NAV
₹17.41
₹288.00
Fund Started
25 Nov 2022
01 Aug 2005
Fund Size
₹90.82 Cr
₹1124.88 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
Returns
1 Year | 1.91% | -1.20% |
3 Year | - | 23.45% |
5 Year | - | 15.98% |
1 Year
1.91%
-1.20%
3 Year
-
23.45%
5 Year
-
15.98%
Holding Analysis
Equity | 99.98% | 98.12% |
Cash | 0.02% | 1.87% |
Equity
99.98%
98.12%
Cash
0.02%
1.87%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 22.18% |
Divi's Laboratories Ltd. | 10.66% |
Cipla Ltd. | 10.51% |
Dr. Reddy's Laboratories Ltd. | 9.08% |
Lupin Ltd. | 5.91% |
Torrent Pharmaceuticals Ltd. | 4.64% |
Laurus Labs Ltd. | 4.61% |
Aurobindo Pharma Ltd. | 3.97% |
Alkem Laboratories Ltd. | 3.86% |
Glenmark Pharmaceuticals Ltd. | 3.55% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.77% |
Ajanta Pharma Ltd. | 6.25% |
Lupin Ltd. | 5.58% |
Glenmark Pharmaceuticals Ltd. | 4.12% |
Cipla Ltd. | 3.74% |
Procter & Gamble Health Ltd. | 3.67% |
Gland Pharma Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.62% |
Dr. Reddy's Laboratories Ltd. | 3.57% |
Alkem Laboratories Ltd. | 3.52% |
Fund Manager
Name | Kayzad Eghlim | Kamal Gada |
Start Date | 03 Dec 2021 | 02 May 2022 |
Name
Kayzad Eghlim
Kamal Gada
Start Date
03 Dec 2021
02 May 2022
About Fund
Description | The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 25 Nov 2022 | 01 Aug 2005 |
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
25 Nov 2022
01 Aug 2005